نتائج البحث - Catherine Richon

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma

    Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma حسب Nathalène Truffaux, Cathy Philippe, Janna Paulsson, Felipe Andreiuolo, Léa Guerrini‐Rousseau, Gaétan Cornilleau, Ludivine Le Dret, Catherine Richon, Ludovic Lacroix, Stéphanie Puget, Birgit Geoerger, Gilles Vassal, Arne Östman, Jacques Grill

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma

    High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma حسب Saloua Toujani, Philippe Dessen, Nathalie Ithzar, Gisèle Danglot, Catherine Richon, Yegor Vassetzky, Thomas Robert, Vladimir Lazar, Jacques Bosq, Lydie Da Costa, Christine Pérot, Vincent Ribrag, Catherine Patte, Joëlle Wiels, Alain Bernheim

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

    Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array حسب Fabrice André, Bastien Job, Philippe Dessen, Attila Tordai, Stefan Michiels, Cornelia Liedtke, Catherine Richon, Kai Yan, Bailang Wang, Gilles Vassal, Suzette Delaloge, Gabriel N. Hortobágyi, W. Fraser Symmans, Vladimir Lazar, Lajos Pusztai

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

    Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma حسب C-H Gattolliat, Laurent F. Thomas, Silvia Anna Ciafrè, Guillaume Meurice, Gwénaël Le Teuff, Bastien Job, Catherine Richon, Valérie Combaret, Philippe Dessen, Dominique Valteau‐Couanet, E May, Pierre Busson, Sétha Douc‐Rasy, Jean Bénard

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

    The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis حسب Muhammad Zaeem Noman, Stéphanie Buart, Jos van Pelt, Catherine Richon, Meriem Hasmim, F. Floc’h, Wiktoria Maria Suchorska, Abdelali Jalil, Yann Lécluse, Faten El Hage, Massimo Giuliani, Christophe Pichon, Bruno Azzarone, Nathalie M. Mazure, Pedro Romero, Fathia Mami‐Chouaib, Salem Chouaı̈b

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas

    Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas حسب Stéphanie Puget, Cathy Philippe, Dorine A. Bax, Bastien Job, Pascale Varlet, Marie‐Pierre Junier, Felipe Andreiuolo, Diana Carvalho, Ricardo Reis, Léa Guerrini‐Rousseau, Thomas Roujeau, Philippe Dessen, Catherine Richon, Vladimir Lazar, Gwénaël Le Teuff, Christian Sainte‐Rose, Birgit Geoerger, Gilles Vassal, Chris Jones, Jacques Grill

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

    Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis حسب Aurélie Auguste, Félix Blanc‐Durand, Marc Deloger, Audrey Le Formal, Rohan Bareja, David Wilkes, Catherine Richon, Béatrice Brunn, Olivier Caron, Mojgan Devouassoux‐Shisheboran, Sébastien Gouy, Philippe Morice, Enrica Bentivegna, Andrea Sboner, Olivier Elemento, Mark A. Rubin, Patricia Pautier, Catherine Genestie, Joanna Cyrta, Alexandra Léary

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy

    ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy حسب Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, Bassam Janji, Andrés Tittarelli, Marie Boutet, Véronique Baud, Elodie Viry, Katy Billot, Arash Nanbakhsh, Thouraya Ben Safta, Catherine Richon, Sophie Ferlicot, Emmanuel Donnadieu, Sophie Couvé, Betty Gardie, Florence Orlanducci, Laurence Albigès, Jérôme Thiery, Daniel Olive, Bernard Escudier, Salem Chouaı̈b

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

    High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial حسب Christophe Massard, Stefan Michiels, Charles Ferté, Marie‐Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loïc Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari, Maud Ngo‐Camus, Rastislav Bahleda, Anas Gazzah, Andrea Varga, Sophie Postel‐Vinay, Yohann Loriot, Caroline Even, Ingrid Breuskin, Nathalie Auger, Bastien Job, Thierry de Baère, Frédèric Deschamps, Philippe Vielh, Jean–Yves Scoazec, Vladimir Lazar, Catherine Richon, Vincent Ribrag, Éric Deutsch, Eric Angevin, Gilles Vassal, Alexander M.M. Eggermont, Fabrice André, Jean‐Charles Soria

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

    Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer حسب Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z. Rizvi, Rosa L. Frias, Jean Paul Thiery, Jean–Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Déas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Brayé, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo‐Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry de Baère, Lambros Tselikas, Éric Solary, Eric Angevin, Alexander Eggermont, Fabrice André, Christophe Massard, Ken A. Olaussen, Jean‐Charles Soria, Benjamin Besse, Luc Friboulet

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: